| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0005 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |